Chronic hypopituitarism was noted in 44% of US veterans with mild traumatic brain injury.
Phthalate exposure effect explained half of the attention deficit in children treated in the ICU.
The vaccine also restored normal glucose tolerance.
The efficacy and safety of abaloparatide was studied in a randomized, double-blind, multicenter trial evaluating fracture prevention in ambulatory, postmenopausal women with osteoporosis.
Andrew Ahmann, MD, discusses the Endocrine Society's new updates on diabetes technology.
Megan Haymart, MD, discusses new ATA guidelines for radioactive iodine treatment in thyroid cancer.
Investigational drug improved vaginal cells and vaginal pH at all dose levels.
Jonathan LoPresti, MD, PhD, discusses the challenges of taking thyroglobulin measurements at ENDO 2016.
Rocio Pereira, MD, discusses the association between diabetes and infectious diseases in developing countries.
People who lived in the warmest homes had a 2.8-cm larger waist circumference than those in the coolest homes
Douglas Ross, MD, discusses changes in ATA guidelines regarding the treatment of hyperthyroidism.
Verbal memory and cognitive flexibility improved after 6 months of estrogen replacement therapy.
The temporary 1-year intestinal bypass device with liraglutide boosts weight loss and improves diabetes control.
Michael McClung, MD, discusses his presentation about new drugs for the treatment of osteoporosis.
Elizabeth Pearce, MD, MSc, and Erik Alexander, MD, elaborate on the revised ATA guidelines about thyroid care in pregnancy.
Sleeve with ileal transposition surgery resulted in better glycemic control in mildly obese patients with diabetes.
The "Paleolithic-type" diet may have long-term health benefits related to obesity.
Infants in the 85th percentile for BMI are at increased risk for obesity by age 6.
High doses of folic acid appeared to mitigate the effects of bone loss.
Bone mineral density was 3.7% to 5.3% lower at all sites.
The risk was greater even for people with low-normal thyroid function.
Clinicians should consider the benefits and risks of hormone therapy when treating this patient population.
The use of these products for thyroid disorders or menopause is often unnecessary.
Cryopresrvation, ovarian transplantion, and ovarian stimulation represent significant advances in the study of fertility preservation.
Many people are "cyclers" who consistently gain and lose weight.
Participants assigned to a whey protein lost more weight at 3 months than those assigned to other proteins or starch.
Researchers discovered for the first time that glucagon-like peptide 1 receptors are in the human brain.
Risk for asthma was increased by 34% in women with polycystic ovary syndrome.
Serum anti-Müllerian hormone levels may help identify women who may lose bone mass the fastest.
A 3D-printed ovarian prosthesis restored the female hormone cycle and supported natural ovulation in mice.
Endocrinology Advisor Articles
- Effect of Sugar-Sweetened Beverages on Obesity Development
- Metformin and PCOS: Improving Menstrual Cycle and Hormone Profiles
- Denosumab May Increase BMD in Women With Primary Hyperparathyroidism
- T2D May Play a Protective Role Against Developing Aortic Diseases
- Risk Factors for Diabetes May Be Identified 20 Years Before Diagnosis
- Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease
- SGLT2 Inhibitors Show High Cardiovascular- and Renal-Protective Effects in T2D
- Type 2 Diabetes Insulin Initiation: Predictors Identified
- Two New Diabetes Medications Now Available
- Managing Acute Pain in Patients With Severe Obesity
- Risk for Congenital Malformations With Antithyroid Drugs
- Occupational Therapy May Benefit Young Adults With Diabetes
- Weight Loss May Improve Pain in Patients With Obesity
- Prior Authorizations Are Creating a Challenge for Clinicians
- Effect of Biologic DMARDs on Spinal Fracture Risk in Ankylosing Spondylitis